JP3345082B2 - オキシアルキン、これを含有する薬剤並びにこの化合物及び薬剤の製造方法 - Google Patents

オキシアルキン、これを含有する薬剤並びにこの化合物及び薬剤の製造方法

Info

Publication number
JP3345082B2
JP3345082B2 JP07054093A JP7054093A JP3345082B2 JP 3345082 B2 JP3345082 B2 JP 3345082B2 JP 07054093 A JP07054093 A JP 07054093A JP 7054093 A JP7054093 A JP 7054093A JP 3345082 B2 JP3345082 B2 JP 3345082B2
Authority
JP
Japan
Prior art keywords
general formula
oxyalkyne
hydroxy
group
prop
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP07054093A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0625135A (ja
Inventor
ウルリッヒ・ザイプ
ウエルナー・フオーレンベルク
ウエルナー・エングルベルガー
コルネリア・ガイスト
ミッヒヤエル・ハウラント
Original Assignee
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング filed Critical グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング
Publication of JPH0625135A publication Critical patent/JPH0625135A/ja
Application granted granted Critical
Publication of JP3345082B2 publication Critical patent/JP3345082B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/42—Radicals substituted by singly-bound nitrogen atoms having hetero atoms attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
JP07054093A 1992-03-30 1993-03-29 オキシアルキン、これを含有する薬剤並びにこの化合物及び薬剤の製造方法 Expired - Fee Related JP3345082B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4210332:0 1992-03-30
DE4210332A DE4210332C1 (enExample) 1992-03-30 1992-03-30

Publications (2)

Publication Number Publication Date
JPH0625135A JPH0625135A (ja) 1994-02-01
JP3345082B2 true JP3345082B2 (ja) 2002-11-18

Family

ID=6455388

Family Applications (1)

Application Number Title Priority Date Filing Date
JP07054093A Expired - Fee Related JP3345082B2 (ja) 1992-03-30 1993-03-29 オキシアルキン、これを含有する薬剤並びにこの化合物及び薬剤の製造方法

Country Status (3)

Country Link
US (1) US5326902A (enExample)
JP (1) JP3345082B2 (enExample)
DE (1) DE4210332C1 (enExample)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103496A (en) 1998-05-29 2000-08-15 Vanderbilt University Isolated and purified 12R-lipoxygenase protein and nucleic acids
JP2004532795A (ja) * 2000-10-10 2004-10-28 ユニバーシティ オブ ノース カロライナ アット チャペル ヒル 上皮および内皮バリアの傍細胞性浸透を促進するための組成物および方法
AU2002246758A1 (en) * 2000-12-29 2002-07-16 Vanderbilt University Epididymal lipocalin gene and uses thereof
EP1572933A4 (en) 2002-02-13 2007-09-05 Univ Duke MODULATION OF THE IMMUNE RESPONSE BY POLYPEPTIDES AS AN ANSWER TO NONPEPTIDIC BINDING STRENGTH
WO2006031210A1 (en) 2003-05-29 2006-03-23 Board Of Regents, The University Of Texas Systems Jabi as a prognostic marker and a therapeutic target for human cancer
CN1984668A (zh) * 2004-05-14 2007-06-20 北卡罗来纳大学查珀尔希尔分校 作为涉及盐和/或体液稳态的疾病的治疗剂和诊断剂的尿鸟苷蛋白原及合成的类似物或自其衍生的蛋白酶解产物
EP2484780A1 (en) 2004-07-23 2012-08-08 The University of North Carolina At Chapel Hill Methods and materials for determining pain sensibility and predicting and treating related disorders
AU2006249323B2 (en) 2005-05-27 2012-08-30 The University Of North Carolina At Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
US8703769B2 (en) * 2005-07-15 2014-04-22 The University Of North Carolina At Chapel Hill Use of EGFR inhibitors to prevent or treat obesity
US20100292339A1 (en) * 2005-10-05 2010-11-18 Zeisel Steven H Genetic Polymorphisms Predictive of Nutritional Requirements for Choline in Subjects
US20090253585A1 (en) * 2005-11-30 2009-10-08 Luda Diatchenko Identification of Genetic Polymorphic Variants Associated With Somatosensory Disorders and Methods of Using the Same
WO2008092153A2 (en) 2007-01-26 2008-07-31 University Of Louisville Research Foundation, Inc. Modification of exosomal components for use as a vaccine
US20100172937A1 (en) * 2007-05-03 2010-07-08 Kotwal Girish J Enveloped virus neutralizing compounds
WO2009094636A2 (en) * 2008-01-25 2009-07-30 The University Of North Carolina At Chapel Hill Ixodes scapularis salivary proteins and methods of use for modulation of the alternative complement pathway
US8518405B2 (en) 2009-10-08 2013-08-27 The University Of North Carolina At Charlotte Tumor specific antibodies and uses therefor
US9346803B2 (en) 2011-10-17 2016-05-24 Vanderbilt University Indomethacin analogs for the treatment of castrate-resistant prostate cancer
WO2014028847A1 (en) 2012-08-17 2014-02-20 The University Of North Carolina At Chapel Hill Water soluble nitric oxide-releasing polyglucosamines and uses thereof
EP3052125B1 (en) 2013-10-01 2020-09-30 University of Mississippi Medical Center Elastin-like polypeptide coupled to therapeutic agent for delivery during pregnancy
CN107949569B (zh) 2015-06-18 2022-05-31 新加坡国立大学 新型凝血酶抑制剂
EP3313866B1 (en) 2015-06-29 2024-11-20 University Of Louisville Research Foundation, Inc. Compositions and methods for treating cancer and promoting wound healing
US20180362974A1 (en) 2015-07-02 2018-12-20 University Of Louisville Research Foundation, Inc. EDIBLE PLANT-DERIVED MICROVESICLE COMPOSITIONS FOR DELIVERY OF miRNA AND METHODS FOR TREATMENT OF CANCER
WO2017117512A2 (en) 2015-12-30 2017-07-06 Marshall University Research Corporation Compositions and methods for treating retinopathy
AU2018205823A1 (en) 2017-01-03 2019-07-18 The University Of North Carolina At Chapel Hill Nitric oxide-releasing alginates as biodegradable antibacterial scaffolds and methods pertaining thereto
CN110461338A (zh) 2017-03-28 2019-11-15 北卡罗来纳大学查佩尔希尔分校 作为可生物降解抗菌支架的释放一氧化氮的聚氨基糖苷类和其制备方法
WO2018189687A1 (en) 2017-04-10 2018-10-18 The University Of North Carolina At Chapel Hill Compounds, compositions and methods for inhibiting a pathogen and/or modifying mucus
JP7115774B2 (ja) 2017-05-11 2022-08-09 マーシャル ユニバーシティー リサーチ コーポレーション 肺高血圧症を処置する組成物および方法
JP2021503029A (ja) 2017-11-15 2021-02-04 ザ ユニバーシティ オブ ノース カロライナ アット チャペル ヒルＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｎｏｒｔｈ Ｃａｒｏｌｉｎａ Ａｔ Ｃｈａｐｅｌ Ｈｉｌｌ 抗菌性足場としての一酸化窒素放出性超分岐化合物およびそれに関する方法
WO2019173539A1 (en) 2018-03-06 2019-09-12 The University Of North Carolina At Chapel Hill Nitric oxide-releasing cyclodextrins as biodegradable antibacterial scaffolds and methods pertaining thereto
WO2020139857A1 (en) 2018-12-28 2020-07-02 The University Of North Carolina At Chapel Hill Nitric oxide-releasing antibacterial polymers and scaffolds fabricated therefrom and methods pertaining thereto
CN113677334B (zh) 2019-02-01 2024-04-09 马歇尔大学科研协会 瞬时受体电位melastatin 8(trpm8)拮抗剂和相关方法
EP3930690A4 (en) 2019-03-01 2023-03-22 The University of North Carolina at Chapel Hill POLYMERS WITH EXTENDED NITROGEN MONOXIDE RELEASE VIA FUNCTIONALIZED MESOPOROUS SILICON DIOXIDE NANOPARTICLES
WO2024107866A1 (en) 2022-11-15 2024-05-23 Celularity Inc. Compositions and methods for treating cancer
WO2024148248A1 (en) 2023-01-05 2024-07-11 Celularity Inc. Dermal rejuvenation composition comprising placenta derived biomaterial and uses thereof
WO2024167694A2 (en) 2023-02-06 2024-08-15 Celularity Inc. Placental extracellular matrices for ocular delivery of ophthalmic therapeutic agents

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652584A (en) * 1984-07-13 1987-03-24 Mcneilab, Inc. Acetylenic phenoxypropanol derivatives and pharmaceutical compositions for the treatment of hypertension
SU1600627A3 (ru) * 1985-05-08 1990-10-15 Е.И.Дюпон Де Немур Энд Компани (Фирма) Способ получени 2-замещенных 1-нафтолов
US4897422A (en) * 1987-02-10 1990-01-30 Abbott Laboratories Lipoxygenase inhibiting compounds
CA1336099C (en) * 1987-04-24 1995-06-27 James B. Summers, Jr. Urea based lipoxygenase compounds
US4937373A (en) * 1988-12-08 1990-06-26 Hoffmann-La Roche Inc. Substituted naphthalene carboxylic acids
US5220059A (en) * 1990-04-19 1993-06-15 Abbott Laboratories Lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids
DE4023742A1 (de) * 1990-07-26 1992-01-30 Gruenenthal Gmbh Substituierte phenylacetylene, diese enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel

Also Published As

Publication number Publication date
US5326902A (en) 1994-07-05
JPH0625135A (ja) 1994-02-01
DE4210332C1 (enExample) 1993-07-15

Similar Documents

Publication Publication Date Title
JPH0625135A (ja) オキシアルキン、これを含有する薬剤並びにこの化合物及び薬剤の製造方法
EP0576350B1 (fr) Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
JP2923014B2 (ja) リポキシゲナーゼ抑制化合物
JPS63284155A (ja) リポキシゲナーゼ抑制化合物
US5112848A (en) Furan and pyrrole containing lipoxygenase inhibiting compounds
EP1095020B1 (fr) Derives de 2-aminopyridines, leur utilisation en tant que medicaments et compositions pharmaceutiques les contenant
JPH04504261A (ja) 尿素系リポキシゲナーゼ阻害化合物
US4946841A (en) Pyridazine 3,5-dihydroxy carboxylic acids and derivatives thereof, the use thereof for hypercholesterolemia
EP0624575A1 (fr) Indoles substitués et les compositions pharmaceutiques qui les contiennent
EP0563715B1 (de) Oxyalkine, diese enthaltende Arzneimittel sowie ein Verfahren zur Herstellung dieser Verbindungen und Arzneimittel
JPS59161377A (ja) ピペリジンジオン誘導体、その製造方法及びそれを含む薬剤
JPS60132935A (ja) フエニルセリン誘導体及びその製造方法
US5202349A (en) Substituted phenylacetylenes, pharmaceutical compositions containing these compounds and processes for the preparation of these compounds and compositions
US4588715A (en) Heptenoic acid derivatives
JP4094955B2 (ja) 置換アミノ基を有するテルフェニル化合物
JP3163173B2 (ja) 置換された３，４− ジヒドロナフタリン、これを化合物を含有する薬剤並びにこの化合物及び薬剤を製造する方法
EP0378991A1 (en) Certain pyrrolylphenyl-substituted hydroxamic acid derivatives
JPS5982385A (ja) Ｎ−置換−２−（１−イミダゾリル）インド−ル、その製法および該化合物を含有する医薬製剤
JPH069571A (ja) イミダゾリルフエノール誘導体、これを含有する薬剤並びにこの化合物及び薬剤を製造する方法
FR2486076A1 (fr) Aminocyclopentanone amides, leur preparation et compositions pharmaceutiques qui les contiennent
JPH0629264B2 (ja) ２‐アミノ‐５‐ヒドロキシ‐４‐ピリミドン
US4906667A (en) Phenyl hydroxamic acids including a hetero-containing substituent
JP3259191B2 (ja) ２，２′−アンヒドロアラビノシルチミン誘導体の合成法
JPH07173120A (ja) 置換芳香族カルボン酸誘導体
JP2559814B2 (ja) カテコール誘導体及びこれを含有する医薬製剤

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20020723

LAPS Cancellation because of no payment of annual fees